" class="no-js "lang="en-US"> FDA Archives - Medtech Alert
Tuesday, February 07, 2023

Sort by:

Date

Top Post

Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience

Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]

Sandoz Biologics License Application for Proposed Biosimilar Denosumab Accepted by US FDA

Sandoz, a global leader in off-patent (generic and biosimilar) medicines, today announced that the US […]

Egret Therapeutics Receives FDA Clearance of IND Application for EGT 101 for Treatment of Delayed Cerebral Ischemia

Egret Therapeutics, a clinical-stage biotechnology company focused on developing transformative therapies for neurological conditions, has […]

Orexo Submits New Drug Application to FDA for OX124, a High-dose Rescue Medication for Opioid Overdose

Orexo AB announces the submission of a New Drug Application (NDA) to the US Food and […]

RefleXion Receives FDA Clearance for Biology-Guided Radiotherapy Treatment for Early and Late-stage Cancers

RefleXion Medical, a therapeutic oncology company, today announced the US Food and Drug Administration (FDA) […]

Jesduvroq Approved by US FDA for Anaemia of Chronic Kidney Disease in Adults on Dialysis

GSK today announced that the US Food and Drug Administration (FDA) has approved Jesduvroq (daprodustat), […]

Genoscience Pharma receives FDA Orphan Drug Designation for ezurpimtrostat to treat HepatoCellular Carcinoma (HCC)

Genoscience Pharma, a clinical-stage biotech company developing unique lysosomotropic drug candidates for the treatment of […]

Ellipses Pharma Announces FDA Approval of IND Application for EP0042 for Patients With Acute Myeloid Leukaemia

Ellipses Pharma, a global drug development company focused on accelerating the development of cancer medicines […]

Ionis receives FDA Fast Track designation for Olezarsen in patients with Familial Chylomicronemia Syndrome

Ionis Pharmaceuticals today announced that the United States Food and Drug Administration (FDA) has granted […]

Xeris Biopharma Announces FDA Grants Orphan-drug Exclusivity for Recorlev

Xeris Biopharma, a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing […]

Nanoscope Therapeutics Receives Fast Track Designation by the FDA for MCO-010 for the Treatment of Stargardt Disease

Nanoscope Therapeutics, a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today announced […]

  1. Halozyme Appoints Barbara Duncan to its Board of Directors Read more
  2. Dianosic Raises €4.7M to Bring Treatment for Chronic Rhinitis into Clinical Trial Read more
  3. Clexio and Genetika+ Announce Partnership Using Proprietary Antidepressant Screening Platform Read more
  4. Mihir Patel Joins Cambia Health Solutions as Chief Pharmacy Officer Read more
  5. Sandoz Biologics License Application for Proposed Biosimilar Denosumab Accepted by US FDA Read more